Sanofi (NASDAQ:SNY) Given Average Rating of “Hold” by Brokerages

Sanofi (NASDAQ:SNY) has been given an average rating of “Hold” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $55.00.

SNY has been the subject of a number of recent research reports. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 27th. Morgan Stanley initiated coverage on shares of Sanofi in a report on Tuesday, January 23rd. They issued an “equal weight” rating and a $55.00 target price for the company. Finally, TheStreet lowered shares of Sanofi from a “b” rating to a “c” rating in a report on Friday, February 9th.

Sanofi Trading Up 0.7 %

Shares of SNY opened at $46.24 on Tuesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. Sanofi has a 1 year low of $42.63 and a 1 year high of $57.82. The company has a 50 day simple moving average of $47.59 and a two-hundred day simple moving average of $48.76. The firm has a market cap of $116.97 billion, a P/E ratio of 19.59, a price-to-earnings-growth ratio of 1.72 and a beta of 0.61.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, February 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.05). Sanofi had a net margin of 12.56% and a return on equity of 27.47%. The company had revenue of $11.76 billion for the quarter, compared to analysts’ expectations of $13.02 billion. On average, equities analysts expect that Sanofi will post 4.16 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Thursday, June 6th. Shareholders of record on Friday, May 10th will be paid a dividend of $1.478 per share. This represents a yield of 2.98%. This is a positive change from Sanofi’s previous annual dividend of $1.38. The ex-dividend date of this dividend is Thursday, May 9th. Sanofi’s payout ratio is presently 58.47%.

Institutional Trading of Sanofi

Several institutional investors and hedge funds have recently made changes to their positions in the business. Arrowstreet Capital Limited Partnership raised its holdings in shares of Sanofi by 276.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 3,362,112 shares of the company’s stock valued at $172,611,000 after acquiring an additional 2,468,271 shares in the last quarter. Morgan Stanley raised its holdings in shares of Sanofi by 19.3% in the fourth quarter. Morgan Stanley now owns 7,733,069 shares of the company’s stock valued at $374,513,000 after acquiring an additional 1,251,199 shares in the last quarter. Armistice Capital LLC bought a new stake in shares of Sanofi in the fourth quarter valued at about $51,520,000. Perceptive Advisors LLC bought a new stake in shares of Sanofi in the first quarter valued at about $41,800,000. Finally, Point72 Asset Management L.P. bought a new stake in shares of Sanofi in the fourth quarter valued at about $38,108,000. 10.04% of the stock is currently owned by institutional investors.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.